Schedule 13G

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13G

 

Under the Securities Exchange Act of 1934

 

 

ABIOMED, INC.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

 

 

003654100

                                (CUSIP Number)                                

Martin P. Sutter

Essex Woodlands Health Ventures Fund VI, L.P.

Essex Woodlands Health Ventures Fund VII, L.P.

21 Waterway Avenue, Suite 225

The Woodlands, Texas 77380

(281) 364-1555

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

March 28, 2007

(Date of Event which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨ Rule 13G-1(b)

x Rule 13G-1(c)

¨ Rule 13G-1(d)

 

*   The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

SCHEDULE 13G

CUSIP No. 003654100       Page 2 of 20 Pages

 

  1  

NAME OF REPORTING PERSON

S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

    
                Essex Woodlands Health Ventures Fund VI, L.P.    
  2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP  
  (a)  ¨  
    (b)  x    
  3   SEC USE ONLY  
         
  4   CITIZENSHIP OR PLACE OF ORGANIZATION  
                Delaware    
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH		     5  SOLE VOTING POWER
 
                  781,818
    6  SHARED VOTING POWER
 
                  -0-
    7  SOLE DISPOSITIVE POWER
 
                  781,818
    8  SHARED DISPOSITIVE POWER
 
                  -0-
  9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON    
                781,818    
10   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES   ¨
         
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
                2.4%    
12   TYPE OF REPORTING PERSON  
                PN    

 

CUSIP No. 003654100       Page 3 of 20 Pages

 

  1  

NAME OF REPORTING PERSON

S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

    
                Essex Woodlands Health Ventures VI, L.P.    
  2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP  
  (a)  ¨  
    (b)  x    
  3   SEC USE ONLY  
         
  4   CITIZENSHIP OR PLACE OF ORGANIZATION  
                Delaware    
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH		     5  SOLE VOTING POWER
 
                  781,818
    6  SHARED VOTING POWER
 
                  -0-
    7  SOLE DISPOSITIVE POWER
 
                  781,818
    8  SHARED DISPOSITIVE POWER
 
                  -0-
  9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON    
                781,818    
10   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES   ¨
         
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
                2.4%    
12   TYPE OF REPORTING PERSON  
                PN    

 

CUSIP No. 003654100       Page 4 of 20 Pages

 

  1  

NAME OF REPORTING PERSON

S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

    
                Essex Woodlands Health Ventures VI, L.L.C.    
  2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP  
  (a)  ¨  
    (b)  x    
  3   SEC USE ONLY  
         
  4   CITIZENSHIP OR PLACE OF ORGANIZATION  
                Delaware    
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH		     5  SOLE VOTING POWER
 
                  781,818
    6  SHARED VOTING POWER
 
                  -0-
    7  SOLE DISPOSITIVE POWER
 
                  781,818
    8  SHARED DISPOSITIVE POWER
 
                  -0-
  9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON    
                781,818    
10   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES   ¨
         
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
                2.4%    
12   TYPE OF REPORTING PERSON  
                OO    

 

CUSIP No. 003654100       Page 5 of 20 Pages

 

  1  

NAME OF REPORTING PERSON

S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

    
                Essex Woodlands Health Ventures Fund VII, L.P.    
  2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP  
  (a)  ¨  
    (b)  x    
  3   SEC USE ONLY  
         
  4   CITIZENSHIP OR PLACE OF ORGANIZATION  
                Delaware    
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH		     5  SOLE VOTING POWER
 
                  1,818,182
    6  SHARED VOTING POWER
 
                  -0-
    7  SOLE DISPOSITIVE POWER
 
                  1,818,182
    8  SHARED DISPOSITIVE POWER
 
                  -0-
  9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON    
                1,818,182    
10   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES   ¨
         
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
                5.6%    
12   TYPE OF REPORTING PERSON  
                PN    

 

CUSIP No. 003654100       Page 6 of 20 Pages

 

  1  

NAME OF REPORTING PERSON

S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

    
                Essex Woodlands Health Ventures VII, L.P.    
  2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP  
  (a)  ¨  
    (b)  x    
  3   SEC USE ONLY  
         
  4   CITIZENSHIP OR PLACE OF ORGANIZATION  
                Delaware    
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH		     5  SOLE VOTING POWER
 
                  1,818,182
    6  SHARED VOTING POWER
 
                  -0-
    7  SOLE DISPOSITIVE POWER
 
                  1,818,182
    8  SHARED DISPOSITIVE POWER
 
                  -0-
  9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON    
                1,818,182    
10   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES   ¨
         
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
                5.6%    
12   TYPE OF REPORTING PERSON  
                PN    

 

CUSIP No. 003654100       Page 7 of 20 Pages

 

  1  

NAME OF REPORTING PERSON

S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

    
                Essex Woodlands Health Ventures VII, L.L.C.    
  2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP  
  (a)  ¨  
    (b)  x    
  3   SEC USE ONLY  
         
  4   CITIZENSHIP OR PLACE OF ORGANIZATION  
                Delaware    
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH		     5  SOLE VOTING POWER
 
                  1,818,182
    6  SHARED VOTING POWER
 
                  -0-
    7  SOLE DISPOSITIVE POWER
 
                  1,818,182
    8  SHARED DISPOSITIVE POWER
 
                  -0-
  9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON    
                1,818,182    
10   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES   ¨
         
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
                5.6%    
12   TYPE OF REPORTING PERSON  
                OO    

 

CUSIP No. 003654100       Page 8 of 20 Pages

 

  1  

NAME OF REPORTING PERSON

S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

    
                James L. Currie    
  2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP  
  (a)  ¨  
    (b)  x    
  3   SEC USE ONLY  
         
  4   CITIZENSHIP OR PLACE OF ORGANIZATION  
                United States    
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH		     5  SOLE VOTING POWER
 
                  -0-
    6  SHARED VOTING POWER
 
                  2,600,000
    7  SOLE DISPOSITIVE POWER
 
                  -0-
    8  SHARED DISPOSITIVE POWER
 
                  2,600,000
  9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON    
                2,600,000    
10   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES   ¨
         
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
                8%    
12   TYPE OF REPORTING PERSON  
                IN    

 

CUSIP No. 003654100       Page 9 of 20 Pages

 

  1  

NAME OF REPORTING PERSON

S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

    
                Martin P. Sutter    
  2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP  
  (a)  ¨  
    (b)  x    
  3   SEC USE ONLY  
         
  4   CITIZENSHIP OR PLACE OF ORGANIZATION  
                United States    
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH		     5  SOLE VOTING POWER
 
                  -0-
    6  SHARED VOTING POWER
 
                  2,600,000
    7  SOLE DISPOSITIVE POWER
 
                  -0-
    8  SHARED DISPOSITIVE POWER
 
                  2,600,000
  9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON    
                2,600,000    
10   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES   ¨
         
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
                8%    
12   TYPE OF REPORTING PERSON  
                IN    

 

CUSIP No. 003654100       Page 10 of 20 Pages

 

  1  

NAME OF REPORTING PERSON

S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

    
                Immanuel Thangaraj    
  2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP  
  (a)  ¨  
    (b)  x    
  3   SEC USE ONLY  
         
  4   CITIZENSHIP OR PLACE OF ORGANIZATION  
                United States    
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH		     5  SOLE VOTING POWER
 
                  -0-
    6  SHARED VOTING POWER
 
                  2,600,000
    7  SOLE DISPOSITIVE POWER
 
                  -0-
    8  SHARED DISPOSITIVE POWER
 
                  2,600,000
  9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON    
                2,600,000    
10   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES   ¨
         
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
                8%    
12   TYPE OF REPORTING PERSON  
                IN    

 

CUSIP No. 003654100       Page 11 of 20 Pages

 

  1  

NAME OF REPORTING PERSON

S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

    
                Mark Pacala    
  2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP  
  (a)  ¨  
    (b)  x    
  3   SEC USE ONLY  
         
  4   CITIZENSHIP OR PLACE OF ORGANIZATION  
                United States    
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH		     5  SOLE VOTING POWER
 
                  -0-
    6  SHARED VOTING POWER
 
                  2,600,000
    7  SOLE DISPOSITIVE POWER
 
                  -0-
    8  SHARED DISPOSITIVE POWER
 
                  2,600,000
  9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON    
                2,600,000    
10   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES   ¨
         
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
                8%    
12   TYPE OF REPORTING PERSON  
                IN    

 

CUSIP No. 003654100       Page 12 of 20 Pages

 

  1  

NAME OF REPORTING PERSON

S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

    
                Jeff Himawan    
  2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP  
  (a)  ¨  
    (b)  x    
  3   SEC USE ONLY  
         
  4   CITIZENSHIP OR PLACE OF ORGANIZATION  
                United States    
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH		     5  SOLE VOTING POWER
 
                  -0-
    6  SHARED VOTING POWER
 
                  2,600,000
    7  SOLE DISPOSITIVE POWER
 
                  -0-
    8  SHARED DISPOSITIVE POWER
 
                  2,600,000
  9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON    
                2,600,000    
10   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES   ¨
         
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
                8%    
12   TYPE OF REPORTING PERSON  
                IN    

 

CUSIP No. 003654100       Page 13 of 20 Pages

 

  1  

NAME OF REPORTING PERSON

S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

    
                Petri Vainio    
  2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP  
  (a)  ¨  
    (b)  x    
  3   SEC USE ONLY  
         
  4   CITIZENSHIP OR PLACE OF ORGANIZATION  
                United States    
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH		     5  SOLE VOTING POWER
 
                  -0-
    6  SHARED VOTING POWER
 
                  2,600,000
    7  SOLE DISPOSITIVE POWER
 
                  -0-
    8  SHARED DISPOSITIVE POWER
 
                  2,600,000
  9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON    
                2,600,000    
10   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES   ¨
         
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
                8%    
12   TYPE OF REPORTING PERSON  
                IN    

 

ORIGINAL REPORT ON SCHEDULE 13G

 

Item 1.  

(a)

    Name of Issuer:      
     ABIOMED, Inc.      
 

(b)

    Address of Issuer’s Principal Executive Offices:      
    

22 Cherry Hill Drive

Danvers, MA 01923

      
Item 2.  

(a)

    Name of Person Filing:      
     This Schedule 13G is being filed jointly by Essex Woodlands Health Ventures Fund VI, L.P., a Delaware limited partnership (“Essex VI”), Essex Woodlands Health Ventures Fund VII, L.P., a Delaware limited partnership (“Essex VII”, and together with Essex VI, the “Funds”), Essex Woodlands Health Ventures VI, L.P., a Delaware limited partnership, the general partner of Essex VI (the “Essex VI GP”), Essex Woodlands Health Ventures VII, L.P., a Delaware limited partnership, the general partner of Essex VII (the “Essex VII GP” and together with the Essex VI GP, the “Fund GPs”), Essex Woodlands Health Ventures VI, L.L.C., a Delaware limited liability company, the general partner of Essex VI GP (the “Essex VI General Partner”), Essex Woodlands Health Ventures VII, L.L.C., a Delaware limited company, (“Essex VII General Partner” and together with Essex VI General Partner, the “General Partners”), James L. Currie, an individual, Martin P. Sutter, an individual, Immanuel Thangaraj, an individual, Petri Vainio, an individual, Mark Pacala, an individual and Jeff Himawan an individual (each a “Manager”, collectively, the “Managers”, and together with the Funds, Fund GPs and the General Partners, the “Reporting Persons”).      
 

(b)

    Address of Principal Business Office:      
     The address of the principal business of each of the Reporting Persons is 21 Waterway, Suite 225, The Woodlands, Texas 77380.      
 

(c)

    Citizenship:      
     (i) Essex Woodlands Health Ventures Fund VI, L.P. is a Delaware limited partnership; (ii) Essex Woodlands Health Ventures VI, L.P. is a Delaware limited partnership, (iii) Essex Woodlands Health Ventures VI, L.L.C. is a Delaware limited liability company; (iv) Essex Woodlands Health Ventures Fund VII, L.P. is a Delaware limited partnership; (v) Essex Woodlands Health Ventures VII, L.P. is a Delaware limited partnership, (vi) Essex Woodlands Health Ventures VII, L.L.C. is a Delaware limited liability company; (iv) James L. Currie, Martin P. Sutter, Immanuel Thangaraj, Mark L. Pacala, Petri Vainio and Jeff Himawan are all individuals who are citizens of the United States.      
 

(d)

    Title and Class of Securities:      
     Common Stock      
 

(e)

    CUSIP Number:      
     003654100      
Item 3.   If this statement is filed pursuant to §§ 240.13G-1(b) or 240.13G-2(b) or (c), check whether the person filing is a:   
  (a)    ¨    Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
  (b)    ¨    Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
  (c)    ¨    Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
  (d)    ¨    Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a 8).

  (e)    ¨    An investment adviser in accordance with 240.13G 1(b)(1)(ii)(E);
  (f)    ¨    An employee benefit plan or endowment fund in accordance with 240.13G 1(b)(1)(ii)(F);
  (g)    ¨    A parent holding company or control person in accordance with 240.13G 1(b)(1)(ii)(G);
  (h)    ¨    A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
  (i)    ¨    A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a 3);
  (j)    ¨    Group, in accordance with 240.13G 1(b)(1)(ii)(J).
Item 4.    Ownership.      
   Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.      
   (a)    Amount beneficially owned:      
     

For each of Essex VI, the Essex VI GP and the Essex VI General Partner, 781,818 shares.

For each of Essex VII, the Essex VII GP and the Essex VII General Partner, 1,818,182 shares.

For each of the Managers, 2,600,000 shares.

      
   (b)    Percent of class:      
     

For each of Essex VI, the Essex VI GP and the Essex VI General Partner, 2.4%.

For each of Essex VII, the Essex VII GP and the Essex VII General Partner, 5.6%.

For each of the Managers, 8.0%.

      
   (c)    Number of shares as to which such person has:      
      (i)    Sole power to vote or to direct the vote:      
        

For each of Essex VI, the Essex VI GP and the Essex VI General Partner, 781,818 shares.

For each of Essex VII, the Essex VII GP and the Essex VII General Partner, 1,818,182 shares.

      
      (ii)    Shared power to vote or to direct the vote:      
         For each of the Managers, 2,600,000 shares.      
      (iii)    Sole power to dispose or to direct the disposition of:      
        

For each of Essex VI, the Essex VI GP and the Essex VI General Partner, 781,818 shares.

For each of Essex VII, the Essex VII GP and the Essex VII General Partner, 1,818,182 shares.

      

      (iv)    Shared power to dispose or to direct the disposition of:      
         For each of the Managers, 2,600,000 shares.      
Item 5.    Ownership of Five Percent or Less of a Class   
   If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ¨.   
Item 6.    Ownership of More than Five Percent on Behalf of Another Person      
   N/A      
Item 7.    Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company
   N/A
Item 8.    Identification and Classification of Members of the Group      
   N/A      
Item 9.    Notice of Dissolution of Group      
   N/A      
Item 10.    Certification      
   By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having the purpose or effect.      

SIGNATURES

After reasonable inquiry and to the best of our knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct.

Date: March 29, 2007

 

ESSEX WOODLANDS HEALTH VENTURES

FUND VI, L.P.

     INDIVIDUALS:
By:   Essex Woodlands Health Ventures VI, L.P.,      
      Its General Partner      

/s/ James L. Currie

      Name:   James L. Currie
By:   Essex Woodlands Health Ventures VI, .L.L.C.,      
      Its General Partner      
       

/s/ Martin P. Sutter

By:  

/s/ Martin P. Sutter

     Name:   Martin P. Sutter
Name:   Martin P. Sutter      
Title:   Managing Director      
       
ESSEX WOODLANDS HEALTH VENTURES VI, L.P.      

/s/ Immanuel Thangaraj

    Name:   Immanuel Thangaraj
By:   Essex Woodlands Health Ventures VI, .L.L.C.,      
      Its General Partner      
       

/s/ Mark L. Pacala

By:  

/s/ Martin P. Sutter

     Name:   Mark L. Pacala
Name:   Martin P. Sutter      
Title:   Managing Director      
       

/s/ Jeff Himawan

ESSEX WOODLANDS HEALTH VENTURES VI, L.L.C.     Name:   Jeff Himawan
 

/s/ Martin P. Sutter

      
Name:   Martin P. Sutter      
Title:   Managing Director      

/s/ Petri Vainio

      Name:   Petri Vainio

ESSEX WOODLANDS HEALTH VENTURES FUND VII, L.P.
By:  

Essex Woodlands Health Ventures VII, L.P.,

Its General Partner

By:  

Essex Woodlands Health Ventures VII, .L.L.C.,

Its General Partner

By:  

/s/ Martin P. Sutter

Name:   Martin P. Sutter
Title:   Managing Director
ESSEX WOODLANDS HEALTH VENTURES VII, L.P.
By:  

Essex Woodlands Health Ventures VII, .L.L.C.,

Its General Partner

By:  

/s/ Martin P. Sutter

Name:   Martin P. Sutter
Title:   Managing Director
ESSEX WOODLANDS HEALTH VENTURES VII, L.L.C.
 

/s/ Martin P. Sutter

Name:   Martin P. Sutter
Title:   Managing Director

Exhibit 1

JOINT FILING AGREEMENT

Each of the undersigned agrees that (i) the statement on Schedule 13G relating to the Common Stock of Ziopharm Oncology, Inc., has been adopted and filed on behalf of each of them, (ii) all future amendments to such statement on Schedule 13G will, unless written notice to the contrary is delivered as described below, be jointly filed on behalf of each of them, and (iii) the provisions of Rule 13G-1(k) under the Securities Exchange Act of 1934 apply to each of them. This agreement may be terminated with respect to the obligations to jointly file future amendments to such statement on Schedule 13G as to any of the undersigned upon such person giving written notice thereof to each of the other persons signature hereto, at the principal office thereof.

This Agreement may be executed in any number of counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

Date: March 29, 2007

 

ESSEX WOODLANDS HEALTH VENTURES

FUND VI, L.P.

   INDIVIDUALS:
By:  

Essex Woodlands Health Ventures VI, L.P.,

Its General Partner

    

/s/ James L. Currie

    Name:   James L. Currie

By:

  

Essex Woodlands Health Ventures VI, .L.L.C.,

Its General Partner

    
     

/s/ Martin P. Sutter

By:  

/s/ Martin P. Sutter

   Name:   Martin P. Sutter
Name:   Martin P. Sutter    
Title:   Managing Director    
ESSEX WOODLANDS HEALTH    

/s/ Immanuel Thangaraj

VENTURES VI, L.P.   Name:   Immanuel Thangaraj
By:   Essex Woodlands Health Ventures VI, .L.L.C.,    
 

Its General Partner

    
     

/s/ Mark L. Pacala

    Name:   Mark L. Pacala
By:  

/s/ Martin P. Sutter

    
Name:   Martin P. Sutter    
Title:   Managing Director    
     

/s/ Jeff Himawan

    Name:   Jeff Himawan
ESSEX WOODLANDS HEALTH    
VENTURES VI, L.L.C.    
 

/s/ Martin P. Sutter

    

/s/ Petri Vainio

Name:   Martin P. Sutter   Name:   Petri Vainio
Title:   Managing Director    
     

ESSEX WOODLANDS HEALTH VENTURES

FUND VII, L.P.

By:   Essex Woodlands Health Ventures VII, L.P.,
      Its General Partner
By:   Essex Woodlands Health Ventures VII, .L.L.C.,
      Its General Partner
By:  

/s/ Martin P. Sutter

Name:   Martin P. Sutter
Title:   Managing Director
ESSEX WOODLANDS HEALTH VENTURES VI, L.P.
By:   Essex Woodlands Health Ventures VII, .L.L.C.,
      Its General Partner
By:  

/s/ Martin P. Sutter

Name:   Martin P. Sutter
Title:   Managing Director
ESSEX WOODLANDS HEALTH VENTURES VII, L.L.C.
 

/s/ Martin P. Sutter

Name:   Martin P. Sutter
Title:   Managing Director